相似文献
1
A mechanism-based potent sirtuin inhibitor containing Nε-thiocarbamoyl-lysine (TuAcK).
Bioorg Med Chem Lett. 2011 Aug 15;21(16):4753-7. doi: 10.1016/j.bmcl.2011.06.069. Epub 2011 Jun 22.
2
Simple N(ε)-thioacetyl-lysine-containing cyclic peptides exhibiting highly potent sirtuin inhibition.
Bioorg Med Chem Lett. 2016 Mar 15;26(6):1612-1617. doi: 10.1016/j.bmcl.2016.01.086. Epub 2016 Feb 1.
3
The mimics of N-acyl-lysine derived from cysteine as sirtuin inhibitors.
Bioorg Med Chem Lett. 2018 Aug 1;28(14):2375-2378. doi: 10.1016/j.bmcl.2018.06.030. Epub 2018 Jun 18.
4
Novel thiourea-based sirtuin inhibitory warheads.
Bioorg Med Chem Lett. 2015 Aug 15;25(16):3319-24. doi: 10.1016/j.bmcl.2015.05.058. Epub 2015 May 30.
5
A Selective Cyclic Peptidic Human SIRT5 Inhibitor.
Molecules. 2016 Sep 10;21(9):1217. doi: 10.3390/molecules21091217.
6
Mechanism-based inhibition of Sir2 deacetylases by thioacetyl-lysine peptide.
Biochemistry. 2007 Dec 18;46(50):14478-86. doi: 10.1021/bi7013294. Epub 2007 Nov 21.
7
Mechanism-based inactivators of sirtuin 5: A focused structure-activity relationship study.
Bioorg Med Chem Lett. 2025 Jan 1;115:130017. doi: 10.1016/j.bmcl.2024.130017. Epub 2024 Nov 7.
8
Identification of a cell-active non-peptide sirtuin inhibitor containing N-thioacetyl lysine.
Bioorg Med Chem Lett. 2009 Oct 1;19(19):5670-2. doi: 10.1016/j.bmcl.2009.08.028. Epub 2009 Aug 12.
9
Novel sirtuin inhibitory warheads derived from the N(ε)-acetyl-lysine analog L-2-amino-7-carboxamidoheptanoic acid.
Org Biomol Chem. 2015 Nov 14;13(42):10442-50. doi: 10.1039/c5ob01721a. Epub 2015 Sep 29.
10
Inhibition of human sirtuins by in situ generation of an acetylated lysine-ADP-ribose conjugate.
J Am Chem Soc. 2009 May 27;131(20):6989-96. doi: 10.1021/ja807083y.
引用本文的文献
1
Structural basis of SIRT7 nucleosome engagement and substrate specificity.
Nat Commun. 2025 Feb 4;16(1):1328. doi: 10.1038/s41467-025-56529-y.
2
Current Trends in Sirtuin Activator and Inhibitor Development.
Molecules. 2024 Mar 6;29(5):1185. doi: 10.3390/molecules29051185.
3
Structural Basis of Sirtuin 6-Catalyzed Nucleosome Deacetylation.
J Am Chem Soc. 2023 Mar 29;145(12):6811-6822. doi: 10.1021/jacs.2c13512. Epub 2023 Mar 17.
4
Identification of 2-hydroxybenzoic acid derivatives as selective SIRT5 inhibitors.
Eur J Med Chem. 2022 Nov 5;241:114623. doi: 10.1016/j.ejmech.2022.114623. Epub 2022 Jul 22.
5
Novel Lysine-Based Thioureas as Mechanism-Based Inhibitors of Sirtuin 2 (SIRT2) with Anticancer Activity in a Colorectal Cancer Murine Model.
J Med Chem. 2019 Apr 25;62(8):4131-4141. doi: 10.1021/acs.jmedchem.9b00191. Epub 2019 Apr 15.
6
Cyclic Peptide-Based Sirtuin Substrates.
Molecules. 2019 Jan 24;24(3):424. doi: 10.3390/molecules24030424.
7
Isoxazole-Derived Amino Acids are Bromodomain-Binding Acetyl-Lysine Mimics: Incorporation into Histone H4 Peptides and Histone H3.
Angew Chem Int Ed Engl. 2016 Jul 11;55(29):8353-7. doi: 10.1002/anie.201602908. Epub 2016 Jun 6.
8
Ligand-based virtual screening and inductive learning for identification of SIRT1 inhibitors in natural products.
Sci Rep. 2016 Jan 25;6:19312. doi: 10.1038/srep19312.
9
Novel thiourea-based sirtuin inhibitory warheads.
Bioorg Med Chem Lett. 2015 Aug 15;25(16):3319-24. doi: 10.1016/j.bmcl.2015.05.058. Epub 2015 May 30.
10
Sirtuin inhibitors as anticancer agents.
Future Med Chem. 2014 May;6(8):945-66. doi: 10.4155/fmc.14.44.
本文引用的文献
1
Advances in characterization of human sirtuin isoforms: chemistries, targets and therapeutic applications.
Curr Med Chem. 2011;18(13):1919-35. doi: 10.2174/092986711795590084.
2
Medicinal chemistry of sirtuin inhibitors.
Curr Med Chem. 2011;18(13):1936-46. doi: 10.2174/092986711795590057.
3
Silencing of SIRT2 induces cell death and a decrease in the intracellular ATP level of PC12 cells.
Int J Physiol Pathophysiol Pharmacol. 2011;3(1):65-70. Epub 2011 Feb 20.
4
The sirtuin pathway in ageing and Alzheimer disease: mechanistic and therapeutic considerations.
Lancet Neurol. 2011 Mar;10(3):275-9. doi: 10.1016/S1474-4422(11)70013-8.
5
SIRT1 modulation as a novel approach to the treatment of diseases of aging.
J Med Chem. 2011 Jan 27;54(2):417-32. doi: 10.1021/jm100861p. Epub 2010 Nov 16.
6
Regulation of intermediary metabolism by protein acetylation.
Trends Biochem Sci. 2011 Feb;36(2):108-16. doi: 10.1016/j.tibs.2010.09.003. Epub 2010 Oct 8.
7
Sirtuin regulation of mitochondria: energy production, apoptosis, and signaling.
Trends Biochem Sci. 2010 Dec;35(12):669-75. doi: 10.1016/j.tibs.2010.07.003. Epub 2010 Sep 20.
8
Emerging mitochondrial signaling mechanisms in physiology, aging processes, and as drug targets.
Exp Gerontol. 2011 Feb-Mar;46(2-3):174-7. doi: 10.1016/j.exger.2010.08.024. Epub 2010 Sep 16.
9
Therapeutic potential of activators and inhibitors of sirtuins.
Biofactors. 2010 Sep-Oct;36(5):383-93. doi: 10.1002/biof.112.
10
Sirtuin mechanism and inhibition: explored with N(ε)-acetyl-lysine analogs.
Mol Biosyst. 2011 Jan;7(1):16-28. doi: 10.1039/c0mb00033g. Epub 2010 Sep 15.
Zotero 插件